Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Endophthalmitis in ophthalmological referral centre in Colombia: aetiology and microbial resistance

Rangel, CM., Parra, MM., Corrales, MI., D. Garcia, R. Sánchezávila, Varón, CL., E. Villareal, D. Villarreal, A. Tello, V. Galvis

. 2022 ; 78 (4) : 160-173.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc22020578

Aims: To describe the aetiology and microbial susceptibility profile of endophthalmitis cases treated at an ophthalmological referral centre in Colombia. Material and Methods: A retrospective descriptive study was carried out with all endophthalmitis cases referred to the Fundación Oftalmológica de Santander FOSCAL (Floridablanca, Colombia) from 1 January 2012 to 31 December 2015. Results: 121 eyes of 121 patients were evaluated. 77.7% of them were male and the mean age was 42.9 years. Five of them (4.1%) corresponded to endogenous endophthalmitis, and 116 (95.9%) to exogenous endophthalmitis. Of the latter, 66.9% were associated with trauma (almost one-half of them associated with intraocular foreign body), and 29.5% with intraocular surgery. The most common isolated microorganisms in the exogenous endophthalmitis group corresponded to methicillin-resistant and methicillin-sensitive strains of Staphylococcus epidermidis and Staphylococcus aureus, which were mostly susceptible to imipenem, vancomycin and moxifloxacin and resistant to ceftazidime. Conclusion: Endophthalmitis is a potentially sight-threatening condition, especially in cases of inadequate treatment. Therefore, antimicrobial therapy should be guided by vitreous humour culture to assure that the causative microorganism is susceptible to the selected agent. The results of our study lead us to propose vancomycin, moxifloxacin or imipenem as first-line antimicrobial options.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22020578
003      
CZ-PrNML
005      
20220906160753.0
007      
ta
008      
220815s2022 xr c f 000 0|eng||
009      
AR
024    7_
$a 10.31348/2022/19 $2 doi
035    __
$a (PubMed)35922145
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Rangel, C. M. $u Ophthalmology Foundation of Santander - Carlos Ardila Lulle, (FOSCAL), Floridablanca, Colombia $u Autonomous University of Bucaramanga (UNAB), Bucaramanga, Colombia $u Industrial University of Santander (UIS), Bucaramanga, Colombia
245    10
$a Endophthalmitis in ophthalmological referral centre in Colombia: aetiology and microbial resistance / $c Rangel, CM., Parra, MM., Corrales, MI., D. Garcia, R. Sánchezávila, Varón, CL., E. Villareal, D. Villarreal, A. Tello, V. Galvis
520    9_
$a Aims: To describe the aetiology and microbial susceptibility profile of endophthalmitis cases treated at an ophthalmological referral centre in Colombia. Material and Methods: A retrospective descriptive study was carried out with all endophthalmitis cases referred to the Fundación Oftalmológica de Santander FOSCAL (Floridablanca, Colombia) from 1 January 2012 to 31 December 2015. Results: 121 eyes of 121 patients were evaluated. 77.7% of them were male and the mean age was 42.9 years. Five of them (4.1%) corresponded to endogenous endophthalmitis, and 116 (95.9%) to exogenous endophthalmitis. Of the latter, 66.9% were associated with trauma (almost one-half of them associated with intraocular foreign body), and 29.5% with intraocular surgery. The most common isolated microorganisms in the exogenous endophthalmitis group corresponded to methicillin-resistant and methicillin-sensitive strains of Staphylococcus epidermidis and Staphylococcus aureus, which were mostly susceptible to imipenem, vancomycin and moxifloxacin and resistant to ceftazidime. Conclusion: Endophthalmitis is a potentially sight-threatening condition, especially in cases of inadequate treatment. Therefore, antimicrobial therapy should be guided by vitreous humour culture to assure that the causative microorganism is susceptible to the selected agent. The results of our study lead us to propose vancomycin, moxifloxacin or imipenem as first-line antimicrobial options.
650    07
$a antibakteriální látky $x terapeutické užití $7 D000900 $2 czmesh
650    17
$a endoftalmitida $x epidemiologie $x etiologie $7 D009877 $2 czmesh
650    07
$a oční infekce bakteriální $x farmakoterapie $x komplikace $7 D015818 $2 czmesh
650    07
$a imipenem $x terapeutické užití $7 D015378 $2 czmesh
650    07
$a moxifloxacin $x terapeutické užití $7 D000077266 $2 czmesh
650    07
$a retrospektivní studie $7 D012189 $2 czmesh
650    07
$a vankomycin $x terapeutické užití $7 D014640 $2 czmesh
650    _7
$a lidé $7 D006801 $2 czmesh
700    1_
$a Parra, M. M. $u Ophthalmology Foundation of Santander - Carlos Ardila Lulle, (FOSCAL), Floridablanca, Colombia $u Autonomous University of Bucaramanga (UNAB), Bucaramanga, Colombia
700    1_
$a Corrales, M. I. $u Ophthalmology Foundation of Santander - Carlos Ardila Lulle, (FOSCAL), Floridablanca, Colombia $u Autonomous University of Bucaramanga (UNAB), Bucaramanga, Colombia
700    1_
$a Garcia, D. $u Ophthalmology Foundation of Santander - Carlos Ardila Lulle, (FOSCAL), Floridablanca, Colombia $u Autonomous University of Bucaramanga (UNAB), Bucaramanga, Colombia
700    1_
$a Sánchezávila, R. $u Fernández-Vega University Institute, Ophthalmological Research, Foundation, Oviedo University, Oviedo, Spain
700    1_
$a Varón, C. L. $u Ophthalmology Foundation of Santander - Carlos Ardila Lulle, (FOSCAL), Floridablanca, Colombia $u Industrial University of Santander (UIS), Bucaramanga, Colombia
700    1_
$a Villareal, E. $u Ophthalmology Foundation of Santander - Carlos Ardila Lulle, (FOSCAL), Floridablanca, Colombia $u Autonomous University of Bucaramanga (UNAB), Bucaramanga, Colombia
700    1_
$a Villarreal, D. $u OCULAB-Higuera Escalante Clinical Laboratory
700    1_
$a Tello, A. $u Ophthalmology Foundation of Santander - Carlos Ardila Lulle, (FOSCAL), Floridablanca, Colombia $u Autonomous University of Bucaramanga (UNAB), Bucaramanga, Colombia
700    1_
$a Galvis, V. $u Ophthalmology Foundation of Santander - Carlos Ardila Lulle, (FOSCAL), Floridablanca, Colombia $u Autonomous University of Bucaramanga (UNAB), Bucaramanga, Colombia
773    0_
$w MED00010980 $t Česká a slovenská oftalmologie $x 1211-9059 $g Roč. 78, č. 4 (2022), s. 160-173
856    41
$u https://www.prolekare.cz/casopisy/ceska-slovenska-oftalmologie/2022-4-2/endophthalmitis-in-ophthalmological-referral-centre-in-colombia-aetiology-and-microbial-resistance-131364 $y plný text volně dostupný
910    __
$a ABA008 $b A 202 $c 639 $y p $z 0
990    __
$a 20220815 $b ABA008
991    __
$a 20220906160749 $b ABA008
999    __
$a ok $b bmc $g 1829451 $s 1171831
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 78 $c 4 $d 160-173 $i 1211-9059 $m Česká a slovenská oftalmologie $x MED00010980 $y 131364
LZP    __
$c NLK109 $d 20220906 $b NLK111 $a Meditorial-20220815

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...